Logo
 Home | Sitemap | Contact us | Search | Language
Left Right
Home >> Biotechnology and Genomics >> Cloning and Expression Vectors >> Three Phase of the Development of Plasmid Cloning Vectors


Three phases of the development of plasmid cloning vectors.


Development of plasmid vectors proceeded chronologically in the following three phases. (1) In the first phase, the vectors that were made available during 1973-1976 included pSC101, Co1E1 and pCR1, all of them suffering with the following drawbacks: (i) they replicated poorly, (ii) they carried unsuitable selectable markers and (iii) they carried not more than two restriction sites for cloning.

These drawbacks were taken care of in pBR313, but it was unnecessarily large, half of its DNA being non-essential. This was reduced in size giving rise to pBR322 (4.362kb; both pBR313 and pBR322 were produced in 1977), which remained popular for many years.

In the second phase, the size of plasmid vectors was greatly reduced, because the efficiency of transformation is inversely related to the size of vector, and also because larger plasmids replicate to lower copy number. A number of derivatives of pBR322 were thus released, which included pA TI53, pXf3, pBR327, etc. They made use of antibiotic resistance for selecting recombinant clones. The third phase of the development of plasmid vectors involved (i) incorporation of Hindi fragment of β-galcatosidase gene to permit selection through blue/white colonies due to alpha-complementation (e.g., pUC vectors; see later for alpha complementation).

(ii) incorpora­tion of DNA. sequences from single stranded M 13 phage, for generation of single stranded DNA templates for sequencing, e.g. phagemid vectors, (iii) incorporation of promoter DNA sequences for transcription in vitro, e.g. pGEM vectors .or (iv) incorporation of high expression promoters for expression of large amounts of foreign proteins (e.g. a variety of expression vectors).

 

Left Right